| ¡ Regístrese ahora en R3i! BM Everett, AD Pradhan, DH Solomon, N Paynter, J Macfadyen, ... | | |
| ¡ Regístrese ahora en R3i! PM Ridker, P Libby, JG MacFadyen | | |
| “In vivo” imaging of atherosclerosis A Gallino, M Stuber, F Crea, E Falk, R Corti, J Lekakis, J Schwitter, ... Atherosclerosis 224 (1), 25-36, 2012 | 81 | 2012 |
| † Evaluating the Residual Risk of Recurrent Cardiovascular Events in Contemporary Cardiovascular Outcomes Trials K Serge, Y Daaboul, D Bhatt, PM Ridker, RW Yeh, R Mehran, S Baron, ... Journal of Clinical Lipidology 17 (4), e1-e2, 2023 | | 2023 |
| 0447 AGE AND SEX MODIFY THE ASSOCIATION BETWEEN OSA AND TRADITIONAL AND NOVEL CARDIOVASCULAR RISK FACTORS: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) GR Geovanini, R Wang, J Weng, S Shea, NS Jenny, P Libby, S Redline Journal of Sleep and Sleep Disorders Research 40 (suppl_1), A166-A166, 2017 | 2 | 2017 |
| 0SOA02-1 What is happening inside an atherosclerotic plaque? P Libby Atherosclerosis (Supplements)(Component) 2 (4), 1, 2003 | 1 | 2003 |
| 1 Inflammation and Atherosclerosis: From Bench to Bedside (Plenary Session 2 (PL2)(IHD): Inflammation and Atherosclerosis: From Bench to Bedside)(Special Program) L Peter Circulation journal: official journal of the Japanese Circulation Society 68, 12, 2004 | | 2004 |
| 10 Biomarkers and Use in Precision Medicine P LIBBY, PM RIDKER | | |
| 1048 THE “UNSTABLE” ATHEROSCLEROTIC PLAQUE P Libby Atherosclerosis (Supplements)(Component) 2 (10), e1651, 2009 | | 2009 |
| 1071 PLASMA PENTRAXIN 3 LEVELS REFLECT METABOLIC SYNDROME IN PATIENTS WITH CORONARY ARTERY DISEASE T Miyazaki, S Chiuve, F Sacks, P Ridker, P Libby, M Sagara, M Aikawa Atherosclerosis (Supplements)(Component) 2 (10), e420-e421, 2009 | | 2009 |
| 1081: EICOSAPENTAENOIC ACID REDUCES PULMONARY ENDOTHELIAL CELL ADHESION PROTEIN EXPRESSION WITH IL-6 S Sherratt, P Libby, D Bhatt, H Dawoud, T Malinski, P Mason Critical Care Medicine 50 (1), 539, 2022 | | 2022 |
| 1082: EICOSAPENTAENOIC ACID INCREASES ENDOTHELIAL FUNCTION AND HEME OXYGENASE-1 IN PULMONARY INFLAMMATION S Sherratt, P Libby, H Dawoud, D Bhatt, T Malinski, P Mason Critical Care Medicine 50 (1), 539, 2022 | | 2022 |
| 1084: EICOSAPENTAENOIC ACID FAVORABLY MODULATES PROTEIN EXPRESSION IN PULMONARY ENDOTHELIAL INFLAMMATION S Sherratt, P Libby, D Bhatt, H Dawoud, T Malinski, P Mason Critical Care Medicine 50 (1), 540, 2022 | | 2022 |
| 12-electrocardiography DM Mirvis, AL Goldberger, DL Mann, DP Zipes, P Libby, RO Bonow Braunwald’s heart disease: a textbook of cardiovascular medicine, tenth …, 2015 | 7 | 2015 |
| 13 Rabbit Models of Atherosclerosis M Aikawa, Y Fukumoto, E Rabkin, P Libby Vascular Disease and Injury: Preclinical Research, 175, 2001 | | 2001 |
| 15 Deoxy Δ12, 14 PGJ2 induces procoagulant activity in cultured human endothelial cells S Xie, DJ O’Regan, VV Kakkar, MF Scully Thrombosis and haemostasis 87 (03), 523-529, 2002 | 10 | 2002 |
| 18F-4V for PET–CT Imaging of VCAM-1 Expression in Atherosclerosis M Nahrendorf, E Keliher, P Panizzi, H Zhang, S Hembrador, ... JACC: Cardiovascular Imaging 2 (10), 1213-1222, 2009 | 255 | 2009 |
| 1SY02-5 Inflammatory activators in the acute coronary syndromes P Libby Atherosclerosis (Supplements)(Component) 2 (4), 4, 2003 | | 2003 |
| 2417 Elevated interleukin-6 and interleukin-18 concentrations predict residual inflammatory risk both before and after interleukin-1beta inhibition with canakinumab PM Ridker, J MacFadyen, T Thuren, P Libby European Heart Journal 40 (Supplement_1), ehz748. 0165, 2019 | | 2019 |
| 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 1. Pathogenesis of coronary disease: the … V Fuster, AM Gotto, P Libby, J Loscalzo, HC McGill Journal of the American College of Cardiology 27 (5), 964-976, 1996 | 126 | 1996 |
